FTSE MIB
33.989,09 +359,88 (+1,07%) Dow Jones
38.675,68 +449,98 (+1,18%) Nasdaq
16.156,33 +315,33 (+1,99%) Nikkei 225
38.236,07 -38,03 (-0,10%) Petrolio
78,99 +0,88 (+1,13%) Bitcoin EUR
59.642,12 +402,42 (+0,68%)
I più comprati dagli hedge fund
41,64k follower • 31 simboli Watchlist di Yahoo Finance
Segui questo portafoglio per scoprire e monitorare i titoli più comprati dagli hedge fund nell'ultimo trimestre.
Selezionata da Yahoo Finance
Segui questo portafoglio per scoprire e monitorare i titoli più comprati dagli hedge fund nell'ultimo trimestre.
Contesto
Yahoo Finanza utilizza algoritmi complessi per monitorare e individuare le tendenze nei Mercati Finanziari Internazionali. Ti forniamo queste informazioni sotto forma di portafogli.
Scopri nuove redditizie idee di investimento con lo Screener di Yahoo Finanza.
Che peso viene loro attribuito?Il peso attribuito ai titoli nel portafoglio è equiripartito.
Performance
| Watchlist | Variazione odierna | Rendimento a 1 mese | Rendimento a 1 anno | Rendimento complessivo |
|---|---|---|---|---|
| I più comprati dagli hedge fund | +0.32% | - | - | - |
| ^GSPC | +1.26% | -1.43% | +23.92% | +5413.75% |
31 codici
| Simbolo | Nome dell'azienda | Ultimo prezzo | Variazione | % variazione | Orario mercato | Volume | Vol medio (3 mesi) | Capitalizzazione |
|---|---|---|---|---|---|---|---|---|
| HDB | HDFC Bank Limited | 58.51 | -0.36 | -0.61% | 16:00 GMT-4 | 3,79M | 2,93M | 148,26B |
| TD | The Toronto-Dominion Bank | 54.66 | -3.42 | -5.89% | 16:00 GMT-4 | 8,09M | 2,96M | 96,77B |
| DELL | Dell Technologies Inc. | 125.1 | +1.71 | +1.39% | 16:00 GMT-4 | 3,94M | 8,37M | 89,30B |
| HPE | Hewlett Packard Enterprise Company | 16.86 | +0.33 | +2.00% | 16:00 GMT-4 | 7,95M | 15,50M | 21,92B |
| BIP | Brookfield Infrastructure Partners L.P. | 29.28 | +0.84 | +2.95% | 16:00 GMT-4 | 472,99k | 533,38k | 13,54B |
| APG | APi Group Corporation | 36.95 | -0.39 | -1.04% | 16:00 GMT-4 | 1,73M | 1,62M | 10,13B |
| TAL | TAL Education Group | 13.18 | +0.38 | +2.97% | 16:00 GMT-4 | 7,89M | 7,04M | 8,42B |
| AS | Amer Sports, Inc. | 14.48 | - | - | 16:00 GMT-4 | 1,40M | 1,57M | 7,32B |
| ALIT | Alight, Inc. | 9.3 | +0.09 | +0.98% | 16:00 GMT-4 | 3,67M | 5,47M | 5,22B |
| ATMU | Atmus Filtration Technologies Inc. | 28.44 | -2.48 | -8.02% | 16:00 GMT-4 | 5,74M | 4,25M | 2,37B |
| OCUL | Ocular Therapeutix, Inc. | 6.17 | +0.30 | +5.11% | 16:00 GMT-4 | 4,64M | 2,65M | 954,66M |
| ARR | ARMOUR Residential REIT, Inc. | 19.02 | +0.19 | +1.01% | 16:00 GMT-4 | 1,01M | 1,15M | 927,26M |
| WALD | Waldencast plc | 5.06 | -0.03 | -0.59% | 16:00 GMT-4 | 88,27k | 80,80k | 618,28M |
| EVLV | Evolv Technologies Holdings, Inc. | 3.88 | -0.03 | -0.77% | 16:00 GMT-4 | 1,01M | 1,71M | 603,65M |
| AMRN | Amarin Corporation plc | 0.91 | -0.01 | -0.87% | 16:00 GMT-4 | 464,01k | 1,55M | 373,89M |
| WTI | W&T Offshore, Inc. | 2.33 | +0.05 | +2.19% | 16:00 GMT-4 | 1,83M | 2,72M | 342,18M |
| CYBN | Cybin Inc. | 0.35 | - | - | 16:00 GMT-4 | 2,76M | 5,46M | 265,89M |
| VERU | Veru Inc. | 1.63 | -0.01 | -0.61% | 16:00 GMT-4 | 2,92M | 2,52M | 238,60M |
| MCAA | Mountain & Co. I Acquisition Corp. | 11.56 | +0.01 | +0.09% | 15:36 GMT-4 | - | 84,86k | 199,56M |
| RGLS | Regulus Therapeutics Inc. | 2.65 | -0.04 | -1.49% | 16:00 GMT-4 | 406,15k | 3,25M | 173,48M |
| MYO | Myomo, Inc. | 3.76 | -0.16 | -4.08% | 16:00 GMT-4 | 446,41k | 267,56k | 108,29M |
| CLSD | Clearside Biomedical, Inc. | 1.31 | -0.01 | -0.76% | 16:00 GMT-4 | 99,14k | 385,04k | 97,88M |
| FLFV | Feutune Light Acquisition Corporation | 10.89 | - | - | 16:00 GMT-4 | 2,00 | 31,99k | 86,97M |
| AITR | AI Transportation Acquisition Corp | 10.32 | - | - | 16:00 GMT-4 | 23,31k | 19,65k | 80,89M |
| FTCI | FTC Solar, Inc. | 0.543 | +0.08 | +16.45% | 16:00 GMT-4 | 1,47M | 732,88k | 68,21M |
| XAIR | Beyond Air, Inc. | 1.3 | +0.08 | +6.56% | 16:00 GMT-4 | 327,25k | 303,66k | 59,67M |
| CARA | Cara Therapeutics, Inc. | 0.7782 | +0.01 | +0.78% | 16:00 GMT-4 | 159,13k | 625,00k | 42,54M |
| UNCY | Unicycive Therapeutics, Inc. | 1.12 | - | - | 16:00 GMT-4 | 168,64k | 420,17k | 38,93M |
| KPRX | Kiora Pharmaceuticals, Inc. | 0.5133 | -0.02 | -4.11% | 16:00 GMT-4 | 83,64k | 290,06k | 13,48M |
| BFRI | Biofrontera Inc. | 1.72 | -0.07 | -3.91% | 16:00 GMT-4 | 38,82k | 650,46k | 8,75M |
GlobeNewswireAmarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference
DUBLIN, Ireland and BRIDGEWATER, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that Patrick Holt, Amarin’s president and chief executive officer, is scheduled to participate in fireside chat at the 2024 H.C. Wainwright 2nd Annual BioConnect Investor Conference. H.C. Wainwright 2nd Annual BioConnect Investor Conference (May 20th, 2024; NYC)Date/Time:May 20, 2024, 4:30 p.m. ETWebcast:https://journey.ct.events/view/a719062a-400f-406f-82d4-2463ef546624
PR NewswireRegulus Therapeutics Advances to Cohort 4 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced, after review of all available safety data, the Company initiated screening in the of the fourth cohort of patients in the Phase 1b MAD study of RGSL8429 for the treatment of ADPKD. Patients in the fourth cohort will receive an open label fixed dose of 300 mg of RGLS8429 every other week for three
GlobeNewswireOcular Therapeutix™ to Present at Two Upcoming Investor Conferences
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it will participate at two investor conferences in May: Citizens JMP Life Sciences Confe
